The strategic metal wolfram, better known as tungsten, is at the heart of a dramatic corporate relocation. Almonty Industries Inc., a key player in the sector, has officially moved its corporate headquarters from Toronto, Canada, to Dillon, Montana. This is far more than a change of address; it’s a calculated pivot designed to embed the company directly into the U.S. national security and defense industrial base. The market’s immediate reaction was a powerful endorsement, with shares surging 15.3 percent to $20.62 on April 13.
This relocation is the culmination of a broader strategic shift that investors have been rewarding for months. On its home Canadian exchange, the stock closed at 28.42 CAD recently, marking a staggering 676 percent gain over the past twelve months. The company’s current market capitalization stands at approximately $5.82 billion.
Financing this ambitious transition required significant capital, which Almonty secured in two major moves. First was an oversubscribed initial public offering on the NASDAQ in July 2025, which raised $90 million. This was followed by a subsequent financing round in December 2025 that brought in an additional $129.4 million.
Operationally, Almonty’s growth rests on two distinct geographic pillars. In South Korea, the company has completed Phase 1 construction at its flagship Sangdong mine. This asset is projected to eventually supply around 40 percent of the global demand for tungsten outside of China. Concurrently, the focus in the United States is on the recently acquired Vantage (formerly Gentung) tungsten project in Montana. Production at this site is slated to commence later in 2026.
Should investors sell immediately? Or is it worth buying Almonty?
The move to Montana is explicitly designed to forge closer ties with U.S. government agencies and defense contractors. To facilitate this, Almonty has bolstered its leadership team with figures possessing deep Pentagon connections. Retired Brigadier General Steven L. Allen has been appointed Chief Operating Officer, a role intended to streamline access to U.S. Department of Defense procurement processes. The company is also working with the consulting firm American Defense International to navigate the Washington landscape.
Wall Street analysts are taking note of this strategic repositioning. Several firms have issued bullish ratings for the NASDAQ-listed shares. DA Davidson initiated coverage with a “Buy” rating and a $25 price target, while B. Riley Financial also recommends “Buy” with a $23 target. Oppenheimer is similarly positive, issuing an “Outperform” rating and a $19 target. Not all voices are uniformly optimistic, however, as evidenced by a current “Sell” recommendation from Weiss Ratings.
For its 2025 fiscal year, Almonty reported a net loss, largely attributed to non-cash revaluations of derivative liabilities. Yet the market’s substantial vote of confidence suggests investors are looking beyond the current income statement. They are betting on the company’s potential to become a primary, non-Chinese supplier of a metal critical to defense, aerospace, and industrial manufacturing. The planned production start in Montana this year represents the next concrete test of whether this high-stakes American strategy will deliver.
Ad
Almonty Stock: Buy or Sell?! New Almonty Analysis from April 14 delivers the answer:
The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 14.
Almonty: Buy or sell? Read more here...










